Lifecore Biomedical, Inc. LFCR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s total equity?
- Lifecore Biomedical, Inc. (LFCR) reported total equity of -$28.44M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s total equity changed year-over-year?
- Lifecore Biomedical, Inc.'s total equity decreased by 2228.6% year-over-year, from $1.34M to -$28.44M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s total equity?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s total equity has grown at a -32.4% compound annual growth rate (CAGR), from $201.95M to -$28.44M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.